International Clinical Trial: The efficacy and mechanism of aflibercept in the treatment of corneal neovascularization with dynamic administration time window

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119895) titled 'The efficacy and mechanism of aflibercept in the treatment of corneal neovascularization with dynamic administration time window' on March 5.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Wuhan Aier Hankou Eye Hospital

Condition: Keratonosus

Intervention: 1. Early intervention subgroup of the active stage group :Aflibercept injection into the corneal stroma within <=7 days after the occurrence of CNV 2. The delayed intervention subgroup of the active stage group :Aflibercept was injected into the corneal stroma 8-14 days after the occurrence of CNV 3. Early intervention su...